Company / Interest Expense per Share
TENAX THERAPEUTICS, INC. Interest Expense per Share History
FY2012-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.01
FY2025
5-year range
$0.01 / $2.20
FY2021-FY2025
Trend
-91.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense per Share has fluctuated over the past 7 years, ranging from $-0.01 in FY2012 to $5.04 in FY2013.
Based on SEC 10-K filings.
0.01 in FY2025 with a 10-year CAGR of -21.9%.
Improved from $0.08 to $0.01 over the past 9 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -21.9%
Key checks
Key Insights
- In FY2025, interest expense per share decreased 91.6% year-over-year.
- Peak interest expense per share was recorded in FY2013.
- Lowest interest expense per share in the period was in FY2012.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | -91.6% |
| FY2024 | $0.08 | +2.3% |
| FY2016 | $0.08 | -0.9% |
| FY2015 | $0.08 | -96.4% |
| FY2014 | $2.20 | -56.4% |
| FY2013 | $5.04 | +68811.0% |
| FY2012 | -$0.01 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026